Optime Care CEO Featured in Leading Healthcare Business Publication: Patient-First Approach Addresses Unique Needs of Patients with Orphan or Rare Disorders
Donovan Quill, President and CEO, Optime Care, byline featured on April 29, 2021: Healthcare Business Today
The estimated total economic burden of 379 rare diseases with a prevalence of 15.5 million people in 2019 was $966 billion, including a direct medical cost of $418 billion and an additional $548 billion in indirect and non-medical cost.
Fortunately, a patient-first care model can enable every stakeholder impacted by rare disease to more effectively address compliance and adherence to mitigate costs and improve outcomes.
This article highlights Optime Care’s patient-first business model and how a higher level of care continuity delivered by a patient-first approach strengthens communication, yields rich data for more informed decision making and improves the overall patient experience.
Ideally, the care management solution should meet the needs of everyone involved in the patient’s journey, from specialty drug manufacturers to pharmacists, caregivers and physicians.
